# Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI

> **NCT04481997** · — · COMPLETED · sponsor: **Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA** · enrollment: 1000 (actual)

## Conditions studied

- Type2 Diabetes Mellitus
- Coronary Heart Disease

## Interventions

- **OTHER:** Exposure to Anti-thrombotic treatment agents and glucose lowering therapy

## Key facts

- **NCT ID:** NCT04481997
- **Lead sponsor:** Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-11
- **Primary completion:** 2023-11-04
- **Final completion:** 2024-01-30
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2025-08-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04481997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04481997, "Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04481997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*